Connect with us

Emerging Markets

Luokung Technolgy Corp and FingerMotion 2 Big Data Plays Immune from Didi Global’s (NASDAQ: DIDI) Chinese Contagion

Published

on

didi Global big Data

Government crackdowns in China have had a big negative spillover effect on many Chinese stocks.  DiDi Global (NASDAQ: DIDI) has been acting as a proxy for the rest of the Chinese stocks.  Chinese stocks listed in the U.S. are getting pummeled on security and data-privacy concerns.  Big Data and Chinese stock went into a tailspin after the Cyberspace Administration of China took down Didi’s main app on Independence Day “pending a cybersecurity review.”  The timing of the takedown was one week after its IPO debut and just happened to be on July 4th.  It doesn’t take a detective to figure out politics was in play.  The focus of this article is on 2 Chinese Big Data stocks that are immune from this regulatory risk and were brought down without any thought to the fundamentals.  The key test of Chinese data immunity lies in who owns the data versus who processes the data.  Eventually stocks will decouple and the ones with the strongest fundamentals will rise again.  

Luokung Technology – Leader in Mapping Technology

Luokung Technology (LKCO) is known for its “spatial-temporal big data ” which is really the study of objects or in this case vehicles moving around the city.  Their data is primarily used by ride hailing services.  This means they need to account for vehicle movements, traffic around the vehicle, obstacles, and the movement of people during the planned pickup. The company has also developed a smart city concept that ties traffic, emergency services, delivery, mass transit, and even road repairs into one map that seeks to optimize the movement within the city factoring different priorities like emergency services when they are needed.  A future facet of their business is autonomous driving which will have to factor in not only other vehicles, but pedestrian movements.  If all vehicles have a common interface and are interconnected there can be a general awareness between vehicles allowing everyone to stay safe.  The most difficult part of determining a universal map that consists of cars and pedestrians is connecting to the Internet of Things (IoT) to assist in confirming and predicting pedestrian movement.  The universal driver behind each of their business segments is big data.    

Investor Presentation – BigData Hub Concept

Many data feeds from their digital partners who own and store the data feed into a centralized server where they are dissected, interpreted, and prioritized.  From these data feeds they are able to render a multilayer dimensional map (see below). From this map they are able to generate predictive algorithms capable of figuring the optimal route factoring in traffic.

In essence the company provides DaaS (Data as a Service), SaaS (Software as a Service), PaaS (Platform as a Service), and combinations in between.  Saleya Holdings (eMapgo) which was purchased for $120 million on August 28, 2019 has 3 main revenue stream classifications.  They have map data services, autonomous driving map data services, and in-dash navigation.  

The revenues of the subsidiary are modest at the moment, but represent an enormous emerging market and almost a pure play on the autonomous driving market segment.

The mobile application known as Luokung is primarily a Business to Customer (B2C) situation that utilizes railroad-WiFi in concert with its software apps to provide tailored content that contains relevant information, entertainment, travel, and e-commerce to the long distance rail rider.  The guiding principle behind the service that has over 51 million users is to reduce boredom on the trains and push the idea of discovering new things to do upon arrival.  Advertising is a key component of their model that includes online to offline (O2O) which hopes to engage passengers while enroute, to purchase or do something once they arrive at their destination.  Recommendations are based on users interests which include restaurants, entertainment, accommodations, local snacks, local products, scenic spots, or points of historical significance.  

The Grecent deal with Tencent Holdings (OTCMKTS: TECHY) initially expanded the base of passengers and increased revenue per customer because high-speed rail customers typically spend more.  This eventually morphed into Luokung Location-based Services (LBS) Data Marketing Platform that is a combination of advertising and very detailed maps, points of interest, 20,000 commercial buildings, train stations, shopping malls, and airports.     

They also have Business to Business (B2B) and Business to Government (B2G) services.  These programs operate in real time allowing the business customers like ride hailing services to predict pickup and drop off points and arrival and departure times with greater accuracy. Smart cities seek to control the port of entry, traffic monitoring, and logistical movement using proprietary systems covered by patents and copyrights that allow for the transmission and rendering of extremely detailed maps that are graphically optimized to operated in a low bandwidth infrastructure while bringing the equivalency of terabytes of data.  

Financial Performance

The company has high R&D expenses and high marketing expenses because they operate in a state of continuous improvement in order to keep customers satisfied and retained on their platforms.  The focus of their efforts are on additional features and performance enhancements while at the same time expanding markets and acquiring business or technology that fits. Notes 4&5 in the cost of revenues was primarily intercompany receivables and amortization of intangible assets which serve to only weaken the earnings outlook only in the short run.  .    

LKCO currently has a market capitalization of $515 million and has 318 million shares outstanding.  The company made 3 offerings in 2021 and brought in about $120 million in cash.  They also completed the acquisition of Saleya on March 17, 2021 for $102 million in cash.  They also have strong backing from Geely, a large Chinese car manufacturer and other notable entities and wide industry connections not to mention their cooperation deals with Beidou positioning, Dell, and National Goepspatial.  

Busy Start / Future Catalysts

March: LKCO announced the acquisition of 100% equity interest in EMG, the first-class mapping company. Following the Company’s successful financing of US$120 million, LKCO has completed the acquisition, which has become a wholly owned subsidiary of the Company.

April: The company received a notification letter from Nasdaq stating that it has regained compliance with the requirement rule of minimum bid price in 5550(a)(2).

May: LKCO obtained the contract which is about the new traffic control system and Intelligent Road.
July: It announced a formal strategic cooperation agreement with the National Geospatial Information Center (NGIC) in a range of sectors including geospatial information services. Besides, recently LKCO revealed that it will cooperate with one of the top China’s automakers collecting and managing the data of autonomous driving vehicles.

The stage is set for more acquisitions around the core mapping technology.  They are also winning more contracts in government and with car manufacturers which will boost the financial outlook and perhaps generate the cash they need for more acquisitions.  Processed data is what they sell and it’s quite valuable but the raw data is not something they own.  This is why they are immune to government crackdowns.  The drop in stock price was completely unrelated to government regulation and people will eventually understand that these autonomous cars will need virtual drivers and when they do only a few players in the world like LKCO will be able to take the wheel.  

FingerMotion – Leading InsureTech Player

FNGR has 3 primary business silos.  They have a mobile data and recharge platform, an SMS and MMS payment solutions, and their big data solutions wrapped up in their subsidiary called Sapientus.  These silos are all interconnected because FNGR has direct access to the mobile carriers.  This gives them an unprecedented number of users that can be converted into buying goods and services that FingerMotion is reselling. This availability of user metadata helps them create extremely accurate algorithms that can better predict user behavior in its Big Data arm.


Top Up & Mobile Recharge

The company started in the Top up and mobile recharge business.  In the United States most cell phones are on monthly plans that are paid after usage, but in China the phones add minutes or data in incremental amounts.  FingerMotion has the wholesale license to sell Top up minutes from China Mobile and China Unicom which are the largest telecoms in China, to e-commerce platforms that include AliBaba (NASDAQ: BABA), PingDuoDuo (NASDAQ: PDD), and JD.com (NYSE: JD). These e-commerce platforms have well over a billion users and allow FNGR to market Top up minutes to their respective user bases.  FNGR gets a small sliver of millions of transactions daily.  Their margins are quite thin, but they have no marketing expenses and don’t have to spend money to retain customers like the e-commerce platforms do.  

SMS & MMS

The SMS and MMS business are responsible for most of the gross profit and has been one of the fastest growing business silos in the company.  

 

Big Data

The Big Data business is held in the subsidiary Sapientus.  It is run by a team of seasoned actuaries and data scientists with a specialty in creating algorithms. The life blood of the insurance industry comes down to risk analysis.  The developing insuretec business at Sapientus is driving innovation in the insurance business that enables the real time assessment of an individual based on risk scoring.  They currently have big data agreements with Pacific Life Re and Happy Life Insurance with many more on the way.  

The algorithms developed by their big data research team take many personal factors into account.  However, the data that goes into these algorithms is from non-identifiable people whose information resides on the host server where the data was sourced from.  Think of it as taking a personal profile and instantly type casting them so that they fit into many different molds like a fitness fanatic or a video gamer.  

Their personal identity is lost but their behaviors and what they typically do are turned into an algorithm that uses distributional statistics and cluster variables that would mimic their actual behavior. Insurance risk algorithms would assign risk scores to these behavioral profiles so when queried in real time, that particular individual would be matched against a behavioral profile that was already assigned a risk score and can be immediately quoted.  

The behavioral analytics also have far reaching consequences inside and outside the insurance business.  For example, another application within the field of insurance is fraud detection to ensure the claims match up to the risk profile.  Outside the insurance sector, big data can profile people seeking credit or financial services which represent a huge untapped market due to the unavailability of credit scores in China.  Morphing into the largest credit scoring reporter in China means FNGR could eventually challenge Visa (NYSE: V) or MasterCard (NYSE: MA), American Express (NYSE: AXP) or PayPal (NASDAQ: PYPL) and become a ripe acquisition target for one of these behemoths.  

In fact FNGR should be able to do anything big data provider Snowflake (NASDAQ: SNOW) can do because SNOW is focused behavior around product sales of merchandise while FNGR is more focused on the consumer who is infinitely more complicated.  FNGR uses practically the same structure as SNOW just liess the centralized storage of data. If SNOW was looking toward international expansion FNGR would be on the short list.  When considering the $78 billion market cap of SNOW versus the $120 million FNGR, FNGR might not last even a year on the NASDAQ before they get gobbled up for their unparalleled access to all of China.  

Heavily Shorting the Macro Without Paying Attention to Core Fundamentals

Both stocks FingerMotion and Luokung Technology have active shorts.  The shorts expect continued sector weakness and they have literally done no due diligence on these names.  LKCO has had its short interest rise from 69K to 8.7 million shares in just the past 6 months.  Average daily volume has exploded to 16.5 million.  The short volume is much harder to see in FNGR because it’s traded in the OTC market.  There are 4.2 million shares held at DTC and only 750,000 shares are held by retail as evidenced by the average volume of 20,000 shares traded daily.  That’s only 3% turnover of the real float daily.  The smoking gun signature of the short presence in FNGR are large orders that have been pummeling the bid in quick succession.  

Investment Summary

The market is playing the guilt by association game when it comes to Chinese big data plays.  Any Chinese company that collects, stores, or owns personal data seems to be a target.  Since Chinese companies are not really that well covered or known for their transparency, shorts are pounding on names hoping to play on investors fears that they don’t understand the fundamentals of the business.  This has created an enormous opportunity in a couple of e-commerce and big data plays growing extremely quickly and quietly in China.  Most notably are LKCO and FNGR.  Both of these companies are provided with Big Data and then analyze and manipulate into something that is actionable by the user.  They DON’T OWN THE DATA so they are immune from government intervention.  

Whether it’s finding out where your pickup location is scheduled or an optimized quote on car insurance, Big Data is transforming the lives of the Chinese people.  The Chinese market is enormous so creating disruptive technologies like autonomous drivers or insuretech solutions will catch on and scale very rapidly.  LKCO has invested a tremendous amount into R&D and is on the cusp of monetizing their disruptive solutions to the market.  FNGR is on the verge of rolling out insurtech products that could ultimately transform the Chinese insurance industry and its unthinkable that this name is only worth $120 million when it could completely dominate the insurance market in the coming 2 years.  They are also moving forward with a NASDAQ uplisting that could provide institutional interest that has been lacking while squeezing to shorts to cover their naked positions ahead of the uplisting.        

Disclosure: we hold no position in LKCO or FNGR either long or short and we have not been compensated for this article.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

BioPharma

Cosmos Holdings Inc (NASDAQ: COSM) Huge Short Position Panicks as COSM Rockets Up the Charts

Published

on

Cosmos Holdings Inc (NASDAQ: COSM) is rocketing up the charts northbound since reversing off $0.0675 lows earlier this month where we first gave the heads up on COSM at around a dime in our article here. Since than COSM has rocketed northbound recently surpassing $0.60 per share with speculators pointing at $1 as the next stop. In our previous article on COSM on November 13 when COSM was $0.10 we stated: “COSM was trading well over $3 at the beginning of this year but has been heavily shorted since than with current estimates of well over 5 million shares sold short and almost the entire public float sold short. 

While COSM has been heavily shorted into oblivion, the Company is actually doing quite well recently reporting revenues for the 3 months ended September 30 were $12 million. The Company is successfully developing their business recently closing a deal with Iberica, a European Airline, for in flight distribution of their products. The CEO has bought millions of shares at current levels and COSM is beginning to go viral on social media trending on the sub reddit Short Squeeze, Number #1 on Stocktwits and multiple videos being made on YouTube about a massive short squeeze taking place in small caps. 

COSM Friday December 2, 4PM Close Update: COSM had a wild trading day on Friday dropping to $0.42 in the morning before rocketing up to $0.61 highs. This was followed by another drop to the $0.47 range before COSM rocketed up in late afternoon trading, closing at $0.53 on 205 million shares traded. COSM was up 33% on the day on around $110 million in dollar volume. COSM is setup for an enormous week ahead, looking to overtake the $0.845 from Monday and embark on a blue-sky breakout with $1 as the first stop. We gave the heads up on COSM when the stock was below $0.10 per share at the beginning of November. We will be updating on COSM as soon as anything new happens so make sure you are subscribed to Microcapdaily by entering your email in the box below.  

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

No alternative text description for this imageCosmos Holdings Inc (NASDAQ: COSM) is a global healthcare group that was incorporated in 2009 and is headquartered in Chicago, Illinois. Cosmos Health is engaged in the nutraceuticals sector through its own proprietary lines of products “Sky Premium Life” and “Mediterranation.” Additionally, the Company is operating in the pharmaceutical sector through the provision of a broad line of branded generics and OTC medications and is involved in the healthcare distribution sector through its subsidiaries in Greece and UK serving retail pharmacies and wholesale distributors. Cosmos Health is strategically focused on the R&D of novel patented nutraceuticals (IP) and specialized root extracts as well as on the R&D of proprietary complex generics and innovative OTC products. Cosmos has developed a global distribution platform and is currently expanding throughout Europe, Asia and North America. Cosmos Health has offices and distribution centers in Thessaloniki and Athens, Greece and Harlow, UK. 

The Number #2 post on the subreddit ShortSqueeze currently is titled: COSM about to test resistance. A pump through $0.66 and lift off to over $1.00 is possible now. 

In another post on COSM in the subreddit ShortSqueeze rubio2430 states: “$COSM you cant make this stuff up. this baby is ready for space. the shorts are burying themselves on the daily. constant pr’s, growing fundamentals, no plans on dilutions, dual listing on upstream soon—the list goes on! 

nimble_broccoli replied: Why this is a good play: 

1.) Extremely tiny Marketcap 2.) CEO buying 15’000’000 shares 3.) Good fundamentals, unlike other plays, they actually sell products valued around 10x the valuation. Q1/22 was profitable. 4.) Getting momentum on social media (Reddit Twitter, YT) 

Next catalysts: -Info that they will not be delisted from NASDAQ -Degen and Retail FOMO kicking in -Shorts starting to cover their asses 

In addition, consider this: The stock was somewhere between USD 2 and USD 12 the past ~8 years. Most Hodlers bought back then, do you think they will sell now? Do your own thinking but if one of my stocks dropped 80+ % i d not sell, i d just hope for a miracle or ride it out. Thus, not many regular buy&hold holders of the stock are expected to sell. 

Cosmos operates in the business of full-line pharmaceutical wholesale distribution and serves approximately 1,500 independent retail pharmacies and 40 pharmaceutical wholesalers in Greece region by providing brand-name and generic pharmaceuticals, over-the-counter medicines, vitamins and nutraceuticals. Cosmos invests in technology to enhance safety, distribution and warehousing efficiency and reliability. Specifically, the Company operates a fully automated warehouse system with three robotic systems, two ROWA™ types and one A-frame type, that ensure 0% error selection rate, accelerate order fulfillment, and yield higher cost-efficiency in our distribution center. Cosmos has 3 operating subsidiaries including:

SkyPharm
Sky Pharm SA is headquartered in Thessaloniki, Greece. Sky Pharm trades the excess amounts of about 500 medicines that can be exported within the EU countries. We buy from Greek wholesale pharmaceutical companies and multinational pharmaceutical manufacturers, and export to European markets where demand and prices are substantially higher.
.
DHN
Decahedron Ltd. is a pharmaceutical wholesaler incorporated in the UK in August 2011. It is audited by the MHRA under European GDP (Good Distribution Practices). They are also a full member of the EAEPC and have been audited by TÜV on their behalf.
.
Cosmofarm
Founded in 1994, Cosmofarm is a fully licensed pharmaceutical wholesale company operating in the greater Athens area. The company is approved and authorized by the National Organization for Medicines under Good Distribution Practices to distribute a comprehensive range of pharmaceutical products. Cosmofarm’s core activity is sourcing, procuring, and distributing branded.
.
To Find out the inside Scoop on COSM Subscribe to Microcapdaily.com Right Now by entering your Email in the box below

COSM

Image

COSM business is strong and Q3 highlights include closing a $7.5M capital raise via public offering and signing an exclusive agreement to market and distribute Nickelodeon’s SpongeBob and PAW Patrol kids’ vitamins in Greece and Cyprus, aiming to reach out 11,000 pharmacies and 120 wholesalers in Greece and 780 pharmacies in Cyprus. They also executed a letter of intent for a strategic co-venture agreement with Smart for Life (SMLF) to cross market products and services in their reciprocal markets. COSM also entered into an LOI to acquire ZipDoctor Inc., and entered into an agreement with Virax Biolabs (VRAX), to become the distributor of Monkeypox Virus Real-Time PCR Detection Kits, having the exclusive distribution rights for Greece and Cyprus, with the opportunity to distribute the test kits across Europe on a non-exclusive basis. SkyPharm officially launched its first Sky Premium Life products on Amazon in the United States. Cosmos targets having all 85 SKUs listed on Amazon by year end. COSM entered into an LOI to acquire Pharmaceutical Laboratories CANA S.A., and another LOI to acquire LIFE NLB, Ltd.’s product portfolio, including Bone-Vio® and Bone-X, related to bone health targeting the human gastrointestinal microbiome. 

Last week COSM announced its Sky Premium Life luxury food supplement brand will be sold on Ronda, the official inflight magazine of the airline company Iberia of BRITISH AIRWAYS group. Ronda is available free of charge to the over 10 million passengers who fly Iberian Airlines annually. Iberia Airlines, majority owned by British Airways, has a fleet of 147 aircrafts and engages in over 600 daily flights. 

https://twitter.com/nxtplse/status/1597365583934545920

For More on COSM Subscribe Right Now!

Currently trading at a $36 million market valuation COSM os is 92,008,281 the Company recently reported Q3 Revenues of $12 million down a bit from the same time last year due to a high variation in FX differences between EUR and GBP to USD. COSM was trading over $4 this time last year however OS has increased substantially since then.  COSM is an exciting opportunity in small caps; the stock was shorted into oblivion and currently there are minimum 5.8 million shares short and was way oversold to pennies and it looked as if it would definitely get delisted by the Nasdaq however, led by able CEO Grigorios Siokas, Cosmos is fighting back. Mr. Siokas continues to buy more COSM at current price levels, putting his money where his mouth is as COSM rockets towards $1 which is now just a day and half away if the stock continues up at the same trend.  We will be updating on COSM when more details emerge so make sure you are subscribed to Microcapdaily.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: we hold no position in COSM either long or short and we have not been compensated for this article.

Continue Reading

BioPharma

Cosmos Holdings Inc (NASDAQ: COSM) Heating Up as Co Looks to Take on Massive 5 million Share Short Position

Published

on

Cosmos Holdings Inc (NASDAQ: COSM) is making a rapid move up the charts since recent reversing off $0.0675 lows. The stock was trading well over $3 at the beginning of this year but has been heavily shorted since than with current estimates of well over 5 million shares sold short and almost the entire public float sold short. COSM is quickly emerging as the latest short squeeze at the top of speculators watch lists and is currently trending on stocktwits and the sub reddit ShortSqueeze on Reddit. 

The Company is fighting back against the shorts and planning a lawsuit and CEO Grigorios Siokas recently put his money where his mouth is when he bought 12,500,000 shares of the stock at $0.12 average for about $1.5 million. While in danger of being delisted from the Nasdaq if they don’t get the stock price back over $1 by the end of November the Company is doing well recently reporting its first ever net income on $13,208,504 in revenues for the 3 months ended June 30, 2022. Cosmos is also acquiring ZipDoctor Inc. from American International Holdings Corp (AMIH) 

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Cosmos Holdings Inc (NASDAQ: COSM) is an international healthcare group that was incorporated in 2009 and is headquartered in Chicago, Illinois. On August 2, 2022, the Company filed a Fictitious Firm Name Certificate in Nevada to do business under the name Cosmos Health, Inc. and will seek shareholder approval at its annual shareholders meeting scheduled for December 2, 2022 to amend its Articles of Incorporation for the name change. Cosmos Health is engaged in the nutraceuticals sector through its own proprietary lines of products “Sky Premium Life” and “Mediterranation.” Additionally, the Company is operating in the pharmaceutical sector through the provision of a broad line of branded generics and over-the-counter (“OTC”) medications and is involved in the healthcare distribution sector through its subsidiaries in Greece and UK serving retail pharmacies and wholesale distributors.  

Cosmos operates in the business of full-line pharmaceutical wholesale distribution and serves approximately 1,500 independent retail pharmacies and 40 pharmaceutical wholesalers in Greece region by providing brand-name and generic pharmaceuticals, over-the-counter medicines, vitamins and nutraceuticals. Cosmos invests in technology to enhance safety, distribution and warehousing efficiency and reliability. Specifically, the Company operates a fully automated warehouse system with three robotic systems, two ROWA™ types and one A-frame type, that ensure 0% error selection rate, accelerate order fulfillment, and yield higher cost-efficiency in our distribution center. Cosmos has 3 operating subsidiaries including:

SkyPharm
Sky Pharm SA is headquartered in Thessaloniki, Greece. Sky Pharm trades the excess amounts of about 500 medicines that can be exported within the EU countries. We buy from Greek wholesale pharmaceutical companies and multinational pharmaceutical manufacturers, and export to European markets where demand and prices are substantially higher. The …
DHN
Decahedron Ltd. is a pharmaceutical wholesaler incorporated in the UK in August 2011. It is audited by the MHRA under European GDP (Good Distribution Practices). They are also a full member of the EAEPC and have been audited by TÜV on their behalf. They import and export branded, generic and …
Cosmofarm
Founded in 1994, Cosmofarm is a fully licensed pharmaceutical wholesale company operating in the greater Athens area. The company is approved and authorized by the National Organization for Medicines under Good Distribution Practices to distribute a comprehensive range of pharmaceutical products. Cosmofarm’s core activity is sourcing, procuring, and distributing branded

https://twitter.com/ChairmanOtc/status/1590877348752420866

To Find out the inside Scoop on COSM Subscribe to Microcapdaily.com Right Now by entering your Email in the box below

COSM

ImageOn August 22 Cosmos provided a business update and reported financial results for the second quarter and six months ended June 30, 2022. Revenues were $13,208,504 for the 3 months ended June 30, 2022 compared to $14.8 million for the same period last year. 

Greg Siokas, Chief Executive Officer of Cosmos Health, stated, “We increased our profitability for the first half of 2022 due to the increase of gross profit margin to 14.2% from 11.5% for the respective period of 2021. This increase is attributed mainly to the organic growth of our proprietary nutraceutical brand, Sky Premium Life® (“SPL”). We achieved positive income from operations of $0.2 million for the first half of 2022 compared to a loss of $3.1 million in the same period last year and positive EBITDA of $0.8 million for the first half of 2022 compared to a loss of $2.8 million for the same period last year. Gross profit increased by 23.0% to $3.7 million for the six months ended June 30, 2022. We continue to carefully manage expenses and reduced operating expenses by nearly 43.7% and 41.9% for the three and six months ended June 30, 2022, respectively. During the quarter, we launched a new premium line of nutritional supplements, Mediterranation. The Mediterranation line uses organic herbs and plant extracts such as crataegus, hibiscus, dittany of Crete, oregano, mastic and kritamos, found in specific regions in Greece and the Mediterranean. These unique formulations contain a proprietary blend of vitamins and minerals and are made with the highest quality raw materials. There is high demand among consumers for supplements that utilize high quality Mediterranean ingredients, such as polyphenols, which possess antioxidant and anti-inflammatory properties. We expect the launch of the Mediterranation line will further enhance our growth strategy and we look forward to expanding the product line into new global markets through our growing distribution channels. We also launched our SPL products on Amazon Singapore and are in the process of launching on Amazon United States and Amazon Canada in the third quarter of 2022. These new markets provide an untapped growth opportunities and new audiences for our proprietary SPL brand. Our goal is to grow our portfolio of branded nutraceuticals and reach up to 150 SKUs by the end of 2022.” 

Earlier this year Cosmos announced an LOI to acquire ZipDoctor Inc. from American International Holdings Corp (AMIH). AMIH will continue to manage all aspects of the day-to-day operations of ZipDoctor including product development, marketing, and operational support. ZipDoctor Inc., is a direct-to-consumer subscription-based telemedicine platform, that expects to provide its customers affordable, unlimited, 24/7 access to board certified physicians and licensed mental and behavioral health counselors and therapists. ZipDoctor’s online telemedicine platform will be available to customers across the United States and offers English and Spanish coverage with virtual visits taking place either via the phone or through a secured video chat platform. 

On October 17, 2022, Cosmos entered into a Securities Purchase Agreement with certain institutional investors (the “Purchasers”), pursuant to which the Company agreed to issue and sell, in a public offering, an aggregate of $7,500,000 of securities, consisting of (i) 62,500,000 shares of Common Stock, (ii) pre-funded Warrant in lieu of shares of Common Stock, and (iii) warrants to purchase 125,000,000 shares of Common Stock (the “Common Warrants” and collectively with the Pre-Funded Warrants, the “Warrants”).  Under the terms of the Purchase Agreement, the Company agreed to sell one share of its Common Stock or a Pre-Funded Warrant and two Common Warrants for each share of Common Stock or Pre-Funded Warrant sold at a unit price of $0.12.  For each of 15,662,603 Pre-Funded Warrant sold in the Offering, the number of shares of Common Stock offered were decreased on a one-for-one basis. 

https://twitter.com/AirGoodman24/status/1591938222548189186

 For More on COSM Subscribe Right Now!

Currently trading at a $10 million market valuation COSM is the latest potential short squeeze at the top of speculators watch lists. With $35 million in current liabilities and an inability to collect on accounts receivables that currently stand at over $25 million COSM stock has lagged even as the Company reports its first ever net income on $13,208,504 in revenues for the 3 months ended June 30, 2022. The short position on COSM has grown to well over 5 million shares short and currently the entire public float is sold short. Now that the cat is out of the bag and the stock is surging northbound COSM short squeeze should be at the top of small cap speculators watch lists. We will be updating on COSM when more details emerge so make sure you are subscribed to Microcapdaily.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: we hold no position in COSM either long or short and we have not been compensated for this article.

Continue Reading

BioPharma

Vision Energy Inc., (OTCMKTS: VIHDD) Promo Continues as Phase 1 of Vision Energy’s Green Energy Terminal in Vlissingen Inks Major Engineering Deal

Published

on

Vision Energy Inc., (OTCMKTS: VIHDD) is making a powerful run up the charts up another 7% on Friday on well over $2 million in dollar volume. The Company put out big news on Thursday announcing it has partnered with Linde Engineering, to deliver preliminary Front-End Engineering and Design (FEED) services to its Green Energy Terminal in North Sea Port of Vlissingen, the Netherlands for Phase 1 of Vision Energy’s Green Energy Terminal via the Company’s subsidiary Evolution Terminals BV. Linde Engineering adds a lot of credibility to this deal; the Company is a global industrial gases and engineering company with 2021 sales of $31 billion. 

Speculators love the kind of run that VIHDD is making here, every single day it goes a little bit higher. Starting in the last few days of September Vision Energy stock has steadily been running northbound from around $4 pre-split to $32 pre-split or currently $16 per share after the 2 for 1 forward stock split on November 8. The ticker symbol will lose the extra D in 16 business days from now. Vision Energy has a history of explosive moves up the charts skyrocketing from $2.50 in December 2020, to highs of $50 per share in January 2021. That run however, ended very abruptly and the stock fell back to where it started. 

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Vision Energy Inc.,VisionH2 Announces Name Change and Forward Split (OTCMKTS: VIHD) is an integrated energy company developing assets and solutions for the commercial, industrial and transportation sectors. Leveraging its proven track-record in site and asset procurement, accelerating development and permitting processes, plant design, and grid integration to facilitate low-carbon energy production, supply and distribution. The Company pursues reliable offtake relationships and operating partnerships with energy industry participants and end users seeking carbon abatements across feedstock and fuels. Vision Energy is committed to providing low carbon energy solutions with the highest yield, and where possible, projects are designed to leverage existing gas and power infrastructure to integrate and facilitate import and or distribution of reduced-carbon energy to domestic and global supply chains. Vision Energy is a portfolio company of First Finance, a private equity investment group with offices in Zurich, London and Vancouver. 

Vision Energy’s 100% owned Vlissingen green hydrogen development project located in Vlissingen (Flushing) Netherlands is currently in its Phase 1 Development Plan designed for the construction of approximately 400,000 cubic meters (CBM) of renewable liquid bulk storage capacity comprising 150,000 CBM allocated to Green Ammonia, 180,000 CBM allocated to Renewable Methanol and 70,000 CBM allocated to Biofuels and Liquid Organic Hydrogen Carriers (LOHC). Phase 1 CAPEX is estimated at EUR €450 million, including jetty infrastructure.

Vision Energy Vlissingen is the Company’s launching project, and its focus is on the construction of a 25 MW green hydrogen plant in the Vlissingen Port area, in the province of Zeeland. 

Initial planning and pre-development work having been concluded, Vision Energy submitted the permit application to Vlissingen Municipality and Zeeland Province end of April. This hydrogen plant will produce H2 using electrolysis and will include storage, loading and distribution facilities for evacuating the H2. Initially the plant will produce up to 3,600 tonnes of green hydrogen annually, it is however capable of producing over double that quantity. Furthermore, the concept of the hydrogen plant allows for future expansion of up to at least 100 MW, potentially increasing H2 production to around 30.000 tonnes annually. 

The project site is strategically located on an industrial plot of 30.000m2 in the Vlissingen Oost industrial park. The site is accessible by road, rail and waterway to support the supply and distribution of green hydrogen to consumers in the region, as well as to neighboring industrial companies who are already planning on using green hydrogen to decarbonize their operations. The Vlissingen hydrogen plant also is located next to the Sloecentrale electricity generating plant creating potential synergies. 

Vision Energy’s 50% owned Terneuzen green hydrogen development project located in the North Sea Port of Terneuzen, Netherlands, in partnership with Virya Energy, is developing a 25 MW green hydrogen production facility with tube-trailer loading and integrated distribution facilities. This scalable platform allows the partnership to scale up production capacity at this Site to 75 MW.  At 25 MW the plant will produce up to 3.5 million kilograms of green hydrogen per year, and up to 10.5 million kilograms of H2 output at 75 MW. The Project Site is strategically located near existing high voltage power and gas infrastructure as well as large renewable power producing assets for the supply of green electrons and large industrial customers for future offtake of clean hydrogen. Less than 1,500 metres from the Project Site is the 150kV ground station of TenneT, the Dutch national high voltage grid operator, and less than 1,400 metres away is the connection point to the Yara-Dow-Zeeland Refinery Pipeline which may be repurposed for H2 transport to the Zeeland Refinery in future. Adjacent to the Project Site is the Ghent-Terneuzen Canal, providing water access to the major European Port of Ghent. VisionH2 and Virya plan to build the initial 25 MW electrolysis plant using proven, commercially available technology. Projected development costs for the initial phase of the project are estimated at €35 – €40 million. 

https://twitter.com/stockscan01/status/1590075102946803714

To Find out the inside Scoop on VIHDD Subscribe to Microcapdaily.com Right Now by entering your Email in the box below

On November 10 Vison Energy through its wholly-owned subsidiary Evolution Terminals BV, has partnered with Linde Engineering, to deliver preliminary Front-End Engineering and Design (FEED) services to the project for Phase 1 of Vision Energy’s Green Energy Terminal. Scope includes design and engineering of 150,000 cubic meters (CBM) of Green Ammonia (NH3) storage, truck and barge loading facilities, ship loading and unloading facilities, and utilities, infrastructure and buildings, to accelerate engineering efforts for the Company’s pioneering Green Energy Terminal in North Sea Port of Vlissingen, the Netherlands. Engineering efforts under the agreement have commenced and are anticipated to conclude in April 2023 in support of the Company’s target to reach Final Investment Decision (FID) by Q3 2023. 

Vision Energy is in the advanced stages of planning for the construction and delivery of Northwestern Europe’s first import, storage and handling terminal designed exclusively for hydrogen carriers, renewable energy products and low-carbon fuels. The Company is scheduled to file all remaining environmental and construction permits by December 2022. Total capacity under Phase 1 is for up to 400,000 CBM including 150,000 CBM allocated to Green Ammonia, 180,000 CBM allocated to Renewable Methanol and 70,000 CBM allocated to Biofuels. Linde is a leading global industrial gases and engineering company with 2021 sales of $31 billion (€26 billion). We live our mission of making our world more productive every day by providing high-quality solutions, technologies and services which are making our customers more successful and helping to sustain and protect our planet. 

Vision Energy CEO Andrew Hromyk stated: “Our cooperation with Linde Engineering marks a critical milestone in our development, to deliver this world-class project with the vast global expertise Linde possesses. Our Green Energy Terminal Project will accelerate and advance the energy transition and facilitate Northwestern Europe’s ambition to achieve Net Zero through carbon-abatement and adoption of hydrogen as a core feedstock and fuel.” 
John van der Velden, Senior Vice President Global Sales & Technology at Linde Engineering said: “We are proud to work with Vision Energy on the sustainable development of this ammonia terminal, leveraging our extensive EPC expertise and clean energy technology to enable the green hydrogen economy.”  

 For More on Vison Energy Subscribe Right Now!

Currently trading at a $620 million market valuation Vision Energy is a fully reporting SEC filer OTCQB with $5.5 million in the treasury and is virtually debt free with no convertible debt on the books. The stock has been rocketing northbound over the past week as the Company has put out a number of press releases as things ramp up for its 100% owned Green Energy Hub development project in the North Sea Port of Vlissingen, the Netherlands. This is a massive project; Phase 1 CAPEX is estimated at EUR €450 million, including jetty infrastructure. However, Vision Energy is being promoted and currently the Company does not have the assets to justify this valuation and while the slow steady rise every single day is great, one day the stock could crash, and when it does it could drop very, very quickly. As we said in our last article the stock made a spectacular run back in January 2021 from $2.50 to $50 in a month and is embarking on another big run now which may end similar to the last move which went very high very quickly but dropped just as fast when the promotion ended. Vision Energy will be trading as VIHDD for the next 16 trading days, after which the Company will be assigned a new ticker symbol. We will continue to report on this situation as it unfolds and more information becomes available. We will be updating on VIHDD when more details emerge so make sure you are subscribed to Microcapdaily.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: we hold no position in VIHDD either long or short and we have not been compensated for this article.

Continue Reading

Trending

© All rights reserved.

Sign up now for our 100% FREE Penny Stock Newsletter

Privacy Policy. we will never share your email with anyone.